Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  19 نتائج ل ""FGFR2 fusion""

فلترة النتائج

Subject : protein kinase inhibitors
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion–Positive Cholangiocarcinoma

Subjects: Digestive Diseases - (Gallbladder); Digestive Diseases; 6.1 Pharmaceuticals

  • Source: Cancer Discovery. 12(5)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma

Subjects: Biomedical and Clinical Sciences; Clinical Sciences; Oncology and Carcinogenesis

  • Source: Cancer Discovery. 9(8)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×

EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion–Positive Cholangiocarcinoma

Subjects: Intrahepatic; musculoskeletal diseases; Fibroblast Growth Factor

  • Source: Cancer discovery, vol 12, iss 5Cancer Discov

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×

The Co‐mutational Spectrum Determines the Therapeutic Response in Murine FGFR2 Fusion‐Driven Cholangiocarcinoma

Subjects: Fetal Proteins; 0301 basic medicine; Antimetabolites, Antineoplastic

  • Source: Hepatology. 74:1357-1370

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×

FGFR mRNA Expression in Cholangiocarcinoma and Its Correlation with FGFR2 Fusion Status and Immune Signatures

Subjects: Cholangiocarcinoma; Cancer Research; Bile Ducts, Intrahepatic

  • Source: Clinical cancer research : an official journal of the American Association for Cancer Research. 28(24)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×

TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma

Subjects: 0301 basic medicine; Male; Fibroblast Growth Factor

  • Source: Cancer DiscovCancer discovery, vol 9, iss 8

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×

A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours

Subjects: 0301 basic medicine; Adult; Male

  • Source: British Journal of Cancer

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Evaluation of the clinical cardiac safety of pemigatinib, a fibroblast growth factor receptor inhibitor, in participants with advanced malignancies.

  • Authors : Gong X; Incyte Research Institute, Incyte Corporation, Wilmington, Delaware, USA.; Ji T

Subjects: Morpholines/Morpholines/Morpholines/*adverse effects ; Neoplasms/Neoplasms/Neoplasms/*drug therapy ; Protein Kinase Inhibitors/Protein Kinase Inhibitors/Protein Kinase Inhibitors/*adverse effects

  • Source: Pharmacology research & perspectives [Pharmacol Res Perspect] 2022 Feb; Vol. 10 (1), pp. e00906.Publisher: John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma

Subjects: Humans; Aged; Receptor

  • Source: New England Journal of Medicine , 388 (3) pp. 228-239. (2023)

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma

Subjects: Orphan Drug; Rare Diseases; Clinical Research

  • Source: Journal of Clinical Oncology. 36(3)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  19 نتائج ل ""FGFR2 fusion""